Xcout Intel
Cinclus Pharma
Cinclus Pharma is a clinical-stage pharmaceutical company based in Stockholm, Sweden. The firm is focused on achieving a paradigm shift in the treatment of acid-related diseases by developing and advancing targeted drug candidates like GERD treatments.
Subscribe to see Cinclus Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cinclus Pharma at a glance
Cinclus Pharma is a pharmaceuticals company headquartered in Sweden. Its most recent funding round, Series B, closed in March 2020. Xcout tracks 7 named people at Cinclus Pharma, including Lennart Hansson (Chairman of the Board, Co-founder).
Cinclus Pharma leadership
- Lennart HanssonChairman of the Board, Co-founder
- Anders LundströmNon-executive Director
- David ArmstrongNon-executive Director
- Fredrik JohanssonNon-executive Director
- Helena LevanderNon-executive Director
- Torbjörn KoivistoNon-executive Director
1 more named person on record for Cinclus Pharma, with roles, board committees and tenure — see the full roster →
Cinclus Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | Undisclosed | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cinclus Pharma competitors
A few of Cinclus Pharma's closest competitors — see the full list of competitors and alternatives →
Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada. This compound is currently undergoing advanced (Phase III) clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD), and also as a component of combination therapy with antibiotics to combat Helicobacter pylori (H. pylori) infection. Established in 2018, Phathom Pharmaceuticals maintains its corporate headquarters in Florham Park, New Jersey.
Melius Pharma is a Swedish clinical-stage pharmaceutical company that develops new treatments for severe diseases with high unmet clinical needs. Its primary focus is the development of its lead candidate, ME-015, as a treatment for chronic cough in patients with idiopathic pulmonary fibrosis (IPF).
Egetis Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of treatments for serious, rare diseases with high unmet medical needs. Operating internationally, the public company has its headquarters in Stockholm, Sweden, alongside a growing presence in the United States. Its clinical pipeline targets specialized therapeutic indications to improve patient outcomes.
Pila Pharma AB is a clinical-stage biotechnology company that develops oral TRPV1 antagonists as potential treatments for obesity and diabetes. The company serves patients suffering from these metabolic conditions by advancing innovative, non-injectable drug candidates through preclinical and clinical research.
Purpose Pharma International AB is a European pharmaceutical company headquartered in Stockholm, Sweden. The firm is dedicated to giving people with rare diseases a better quality of life.
Ferring Pharmaceuticals is a specialty biopharmaceutical company that develops and delivers treatments in reproductive medicine, maternal health, gastroenterology, urology, and uro-oncology. The company focuses on helping people build families, supporting maternal and infant health, and providing therapeutic solutions for various medical conditions worldwide.
Get Cinclus Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cinclus Pharma in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access